Archives
|
Entry
|
Blogger
|
Date
▴
|
Location
|
|
Biogen Confirms HQ Move from Cambridge to Suburbs
|
Ryan McBride |
12/02/08 |
Boston
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
Akamai Acquires Acerno, Archemix Adds Eli Lilly to Partner List, Sermo Signs Up Bloomberg Subscribers, & More Boston-Area Deals News
|
Rebecca Zacks |
10/27/08 |
Boston
|
|
Bayer Buys License to ImmunoGen Cancer Drug Technology
|
Luke Timmerman |
10/21/08 |
Boston
|
|
Janius to Replace Sayer as CEO of ImmunoGen
|
Ryan McBride |
09/30/08 |
Boston
|
|
$37 Million for Nanotech Insulation, $25 Million for ImmunoGen, $325 Million for Evergreen Solar, & More Deals News
|
Rebecca Zacks |
06/30/08 |
Boston
|
|
Health 2.0 Firms in the Spotlight, Biogen Board in the Clear, Alnylam in Asia, & More Life Sciences News
|
Rebecca Zacks |
06/25/08 |
Boston
|
|
Immunogen Sells Stock, Raises $25M
|
Erik Mellgren |
06/23/08 |
Boston
|
|
ImmunoGen Scores $1.5M From Biogen Idec
|
Rebecca Zacks |
02/04/08 |
Boston
|
|
ImmunoGen’s Mitch Sayare on What Sustains a Company—and its CEO—Through Decades of Starting Up
|
David Stipp |
01/29/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
